Artificial mitochondria and construction method thereof

By constructing mitochondria with all-organic artificial biofilm-loaded enzymes, the problems of high cost and environmental sensitivity of artificial mitochondria are solved, and the stability and ATP synthesis activity are improved, showing the simulation of mitochondrial function and the potential of bioenergy supply.

CN119020347APending Publication Date: 2024-11-26CHONGQING QUANSHENG PHARM TECH CO LTD +1
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202411166875.9
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-08-23
Publication Date
2024-11-26

AI Technical Summary

Technical Problem

The high preparation cost of existing artificial mitochondria, sensitive to environmental conditions and low reuse rate, limits its further development in biomedical applications.

Method used

Using all-organic artificial biofilm with similar structure to the outer shell of mitochondrial biofilm, loading glucose oxidase, peroxidase and ATP synthetase to construct artificial mitochondria, generating proton gradients through glucose oxidation and using ATP synthetase to generate ATP to simulate mitochondrial oxidation Restore function and ATP synthesis function.

Benefits of technology

The stability of artificial mitochondria and ATP synthesis activity were achieved, the accumulation of hydrogen peroxide was reduced, the activity of glucose oxidase was improved, the mitochondrial function was simulated, and the application of potential bioenergy supply system was used.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN119020347A_ABST
    Figure CN119020347A_ABST
Patent Text Reader

Abstract

The invention relates to the technical field of biology, and discloses an artificial mitochondrion and a construction method thereof, the artificial mitochondrion comprises an artificial biological membrane and full organic molecules loaded on the artificial biological membrane, and the full organic molecules comprise glucose oxidase, peroxidase and ATP synthetase. According to the system constructed by the artificial mitochondria, glucose oxidase is used as an oxidation system, and glucose is oxidized into gluconic acid; peroxidase serves as a reduction system, hydrogen peroxide generated in the system is removed, and ATP synthetase is driven to operate by means of generated proton power potential energy, so that ATP is generated.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to the field of biotechnology, in particular to an artificial mitochondria and a construction method thereof. Background Art

[0002] Molecular bionics, which originated in the 20th century, is a new research field. In the life process of organisms, biological molecules spontaneously form complex and exquisite multi-level structural systems through self-assembly at different levels, from microscopic to macroscopic, and realize various specific biological functions. Molecular bionics is to assemble or prepare new materials and systems with structural and functional bionics at the molecular level based on artificial synthetic molecules or biological primitives, and to study and simulate the structure and function of proteins in organisms. By realizing the assembly and compounding of molecules and supramolecular molecules at the nano and micro scale, it is expected to make breakthroughs in the simulation of proteins and molecular machines, new virus simulators and vaccines, medical bionic surface and interface design, structural bionic materials, smart capsules involved in blood circulation, and even artificial cells.

[0003] At present, the research hotspots in this field include the following systems: biological motor protein assembly system, biomimetic membrane system, and deoxyribonucleic acid (DNA) molecular motor system. As an expert in the field of molecular bionics, Li Junbai, a researcher at the Chinese Academy of Sciences, once pointed out that the development of new solid-state molecular machine devices with high-speed response speed and molecular machine assembly methods has a great and far-reaching significance for the functionalization of molecular machines and even their application in the field of molecular devices.

[0004] In nature, oxidative phosphorylation involves multiple enzymes and has a cascade effect, which is an essential link for producing bioenergy. However, in in vitro applications, the sensitivity of catalytic activity to environmental adaptation has hindered a great challenge. In order to successfully simulate the function of mitochondrial energy production, a mitochondrial hybrid structure was assembled by constructing a cascade reaction catalyzed by multiple enzymes.

[0005] At present, inorganic materials are mostly used in the construction of bionic systems related to mitochondria to simulate their functions. Inorganic materials such as gold nanoparticles, silica and other inorganic materials are used as the supporting skeleton of simulated mitochondria, and metal nanozymes are used to utilize substrates. However, inorganic materials cannot be degraded and easily accumulate in the body, and their safety in the body cannot be guaranteed, resulting in limited future use scenarios of "artificial mitochondria". In addition, nanozymes are widely used in current research. Although they have broad prospects, they often have inherent defects, such as high preparation and purification costs, low operational stability, sensitivity of catalytic activity to environmental conditions, and difficulty in recycling and reuse. These shortcomings limit the further application of nanozymes in biomedicine. Summary of the invention

[0006] Technical problems solved by the present invention:

[0007] It is used to solve the problems of high cost, sensitivity to environmental conditions and low reuse rate of artificial mitochondria mentioned above.

[0008] The technical solution adopted by the present invention is:

[0009] Based on this, the present invention provides an artificial mitochondria and a method for constructing the same. The present invention uses an artificial biological membrane (such as liposomes, etc.) with a similar structure to the outer shell of the mitochondrial biological membrane to load all-organic molecules (glucose oxidase, peroxidase and ATP synthase) to construct "artificial mitochondria". In the system, glucose oxidase is used as an oxidation system to oxidize glucose to gluconic acid; peroxidase is used as a reduction system to remove hydrogen peroxide generated in the system, and the generated proton motive force potential energy is used to drive the ATP synthase to generate ATP. This work provides a new natural-artificial hybrid method for exploring the bioenergy supply system, and provides a certain research basis for the subsequent preparation of "artificial mitochondria". This is of great significance to the construction and application of "artificial mitochondria" and other "artificial cells" in the future.

[0010] To expand on this, it means:

[0011] An artificial mitochondria comprises an artificial biological membrane and all-organic molecules carried by the artificial biological membrane, wherein the all-organic molecules comprise glucose oxidase, peroxidase and ATP synthase.

[0012] According to some embodiments, the artificial biological membrane includes at least one of a liposome membrane, a polymer membrane, a polymer micelle, a cell membrane or an organelle membrane. The cell membrane includes at least one of an erythrocyte membrane, a platelet membrane, a macrophage membrane, a leukocyte membrane, and a tumor cell membrane; the polymer micelle includes at least one of a block polymer micelle, a polyelectrolyte copolymer micelle, a non-covalent bond micelle, and a graft copolymer micelle; the organelle membrane includes at least one of a nuclear membrane, a mitochondrial membrane, an endoplasmic reticulum membrane, a lysosome membrane, a Golgi membrane, a chloroplast membrane, and a vacuole.

[0013] According to some embodiments, the loading amount of glucose oxidase is 0.1-0.5 mg / mL, the loading amount of peroxidase is 0.15-0.5 mg / mL, and the loading amount of ATP synthase is 5-60 μg / mL.

[0014] According to some embodiments, the particle size of the artificial mitochondria is 50 to 2000 nm, preferably 170 to 220 nm.

[0015] According to some embodiments, the zeta potential of the artificial mitochondria is -50 to +50 mV, preferably -13 to -17 mV.

[0016] The aforementioned method for constructing artificial mitochondria comprises the following steps:

[0017] S1: preparing a membrane (i.e., an artificial biomembrane);

[0018] The S2 membrane is mixed with glucose oxidase and peroxidase in a solvent system to obtain a suspension;

[0019] S3 performs extrusion filtration on the suspension;

[0020] The treated liquid after S4 extrusion filtration is mixed with ATP synthase in a solvent system, and the solvent is removed to obtain artificial mitochondria.

[0021] According to some embodiments, in S1, lecithin and cholesterol are dissolved in a solvent system, and the solvent is removed to obtain a lipid membrane; in S2, glucose oxidase and peroxidase are dissolved in PBS to form a system solution, and the system solution is added to the lipid membrane for hydration to obtain a suspension; in S3, the suspension is filtered with a polytetrafluoroethylene filter membrane and then extrusion filtered with a polycarbonate membrane.

[0022] The technical mechanism and beneficial effects adopted by the present invention are as follows:

[0023] The artificial mitochondria provided by the present invention encapsulate all organic molecules (glucose oxidase, peroxidase, ATP synthase) in the form of an artificial biomembrane to form an "artificial mitochondria" system, which can exhibit a certain degree of mitochondrial function. The present invention compares and assembles the redox function and ATP synthesis function of mitochondria. The driving ability of ATP synthase is the proton gradient generated by glucose oxidation, and glucose oxidase can oxidize glucose to produce a proton gradient. However, glucose oxidation is accompanied by the production of hydrogen peroxide, which will inhibit the activity of glucose oxidase. Therefore, peroxidase is added to the system to decompose hydrogen peroxide to avoid the inhibition of glucose oxidase activity.

[0024] (1) The prepared "artificial mitochondria" system has the activity of decomposing glucose to produce gluconic acid and hydrogen peroxide, forming a mitochondrial oxidation system.

[0025] (2) The “artificial mitochondria” system can consume the hydrogen peroxide produced in the system, keeping the system at a low level of hydrogen peroxide and simulating the mitochondrial reduction system.

[0026] (3) The “artificial mitochondria” system can consume glucose and form a proton gradient inside and outside the artificial biological membrane. ATP synthase uses the proton gradient to produce ATP, simulating the ATP synthesis function of mitochondria. BRIEF DESCRIPTION OF THE DRAWINGS

[0027] Figure 1 It is a schematic diagram of the mechanism of the present invention;

[0028] Figure 2 is the TEM image of GHAL;

[0029] Figure 3 The stability results of CHAL are shown in Figure 1 (A is the particle size and PDI stability results of GHAL, and B is the ATP synthesis activity stability results of GHAL after storage for 30 days);

[0030] Figure 4 This is the result diagram of GHAL's cytotoxicity to L02 cells;

[0031] Figure 5 This is the result diagram of the gluconic acid content produced by GHAL and GAL;

[0032] Figure 6 The figure is the result of hydrogen ion content of GHAL (A is the excitation spectrum result of GHAL at an emission wavelength of 511nm, and B is the pH change result of GHAL and GAL).

[0033] Figure 7 The results of hydrogen peroxide content of CHAL (A is the actual picture of the color change of hydrogen peroxide produced by GHAL; B is the wavelength scanning result of GHAL at different time);

[0034] Figure 8 This is a graph showing the ATP content produced by GHAL and GAL. DETAILED DESCRIPTION

[0035] In order to make the purpose, technical scheme and advantages of the embodiments of the present invention clearer, the technical scheme in the embodiments of the present invention will be described clearly and completely below. If the specific conditions are not specified in the embodiments, they are carried out according to conventional conditions or conditions recommended by the manufacturer. If the manufacturer of the reagents or instruments used is not specified, they are all conventional products that can be purchased commercially.

[0036] Example

[0037] 1. Preparation and characterization of artificial mitochondria (GHAL)

[0038] 1. Preparation of Artificial Mitochondrial GHAL

[0039] (1) Lecithin and cholesterol were weighed in a ratio of 50 mg:10 mg, dissolved in 10 mL of dichloromethane as a solvent by ultrasonic water bath, and rotary evaporated at a rotation speed of 100 rpm in a water bath at 37°C to remove dichloromethane. The mixture was sealed with filter paper and transferred to a vacuum drying oven and dried overnight to remove residual dichloromethane to obtain a lipid film.

[0040] (2) Weigh 1 mg of glucose oxidase (GOD) and 1 mg of peroxidase (HRP), add the PBS solution containing GOD and HRP to the dried lipid film for hydration, and rotate it at 200 rpm in a 37°C water bath for hydration. Take a portion of the liposome suspension (GHL, GOD-HRP-Liposme) obtained above, add an appropriate amount of PBS solution for dilution, and then perform particle size and potential detection.

[0041] (3) The liposome suspension was filtered through a 0.45 μm polytetrafluoroethylene filter membrane and then filtered through a 0.20 μm polycarbonate membrane using a liposome extruder to control the particle size of the liposome to less than 200 nm.

[0042] (4) Take 1 mg of ATP synthase and add Triton X-100 to the extracted ATP synthase solution (select ATP synthase extracted from spinach leaves, an enzyme with ATP synthesis function), the final concentration of which in the solution is 0.8%, and the solution contains 20 mM Tricine, 40 mM NaCl, and 5 mM MgCl2; take 1 mg of ATP synthase and add it to 4 mL of GHL suspension, and stir at 4°C for 1 h;

[0043] (5) Add 80 mg / mL Biobeads SM2 to adsorb and remove Triton X-100, stir at 4°C for 0.5 h, repeat once, and finally add 80 mg / mL Biobeads SM2 again, stir at room temperature for 40 min, and then remove Biobeads SM2; the resulting solution is a proteoliposome suspension co-loaded with ATPase, GOD, and HRP - "artificial mitochondria" (GHAL, GOD-HRP-ATPase).

[0044] 2. Characterization of the Artificial Mitochondrial GHAL

[0045] Use a laser particle size analyzer to measure the particle size distribution of the artificial mitochondria. Take out 50 μL of the prepared liposomes, add them to a micro-cuvette, dilute them with water to a volume of 1 mL, add them to the micro-cuvette base, carefully place them in the sample pool, and start the measurement. Repeat the measurement 3 times for each sample.

[0046] Take out 0.50 mL of the prepared GHAL liposome suspension, add it into a four-way cuvette, dilute it to 1.50 mL with water, insert the potential electrode sheet, and use a dynamic light scattering particle size analyzer to measure the Zeta potential of the liposome surface.

[0047] 2. Study on the stability of GHAL preparations

[0048] (1) The prepared GHAL liposome suspension was placed in a 4°C environment, and the changes in the particle size and polymer dispersity index (PDI) of GHAL were detected within one week. The measurements were continued for 7 days to investigate whether the liposomes could be stored stably at 4°C, so as to predict the change trend of the liposomes in vitro.

[0049] (2) Study on the stability of ATP synthesis activity of GHAL

[0050] After GHAL was placed in a -80°C environment for 30 days, UPLC-MS / MS was used to determine the ATP content in the solution after GHAL reacted for 1 hour.

[0051] (3) Transmission electron microscopy observation of GHAL morphology

[0052] The morphology of GHAL was studied by TEM. After the liposomes were purified by centrifugation, they were diluted to an appropriate multiple and 20 μL was added to the copper grid of the transmission electron microscope. After negative staining with phosphotungstic acid, the TEM was scanned and magnified to a certain multiple, and the voltage was 80 kV, and photos were taken and recorded.

[0053] (4) Basic investigation on the biocompatibility of artificial mitochondrial GHAL

[0054] As a new bionic organelle system, GHAL needs to have good biosafety. The CCK-8 experiment was used to examine whether GHAL has obvious cytotoxicity to normal human liver cells (L02).

[0055] The CCK-8 method was used to investigate the cytotoxicity of different concentrations of GHAL in normal human liver cells (L02). L02 cells in the logarithmic growth phase were cultured at 7*10 3 The cells were inoculated at a density of 100 μg / well in a 96-well plate and placed in a 37°C, 5% CO2 incubator for overnight culture, waiting for the cells to adhere to the wall stably. The sample was diluted with complete culture medium to prepare drug-containing culture medium of different concentrations. The grouping was based on the total protein concentration of the three GHAL enzymes diluted into different proportions (10-75 μg / mL) by complete culture medium. The old culture medium in the 96-well plate was removed, rinsed with PBS once, and 100 μL of complete culture medium containing GHAL prepared in each group was added and incubated for 24 hours. After the incubation, the old culture medium of the 96-well plate was aspirated, and 100 μL of serum-free basal culture medium and 10 μL of CCK-8 reagent were added to each well after rinsing with PBS 1-2 times and incubated for 1 hour. The absorbance value was measured at a wavelength of 450 nm using an enzyme reader.

[0056] Cell survival rate = [(As-Ab) / (Ac-Ab)]*100%

[0057] As: absorbance of experimental group; Ab: absorbance of blank group; Ac: absorbance of control group

[0058] (5) Study on the activity of glucose oxidase in artificial mitochondrial GHAL

[0059] Since peroxidase was newly introduced in the construction of GHAL, in order to explore whether the multi-enzyme loading would affect the activity of glucose oxidase, the activity of glucose oxidase in GHAL was comprehensively investigated by liquid chromatography-mass spectrometry and pH probe.

[0060] (5.1) Investigation of glucose oxidase activity (UPLC-MS / MS method)

[0061] Sample treatment: Take 100 μL of GHAL suspension, add 900 μL of 0.1 mol / L glucose solution, take out 100 μL of the reaction solution at different times, add 10 μL of 10% trichloroacetic acid solution to precipitate the protein, then add 100 μL of 0.1% Triton X-100 solution to break the emulsion so that the gluconic acid is released from the liposome, centrifuge at 13000 rpm at 4°C for 5 min, take out the supernatant as the sample mother liquor, and take part of the sample to dilute to 10000 times, mix, and then centrifuge at 13000 rpm at 4°C for 5 min, collect the supernatant in a brown loading bottle, mix, and take 5 μL to load on the UPLC-MS / MS system for analysis.

[0062] After glucose reacts with the GHAL system, a corresponding oxidation product, gluconic acid, will be produced. However, the solution system also contains some hydrogen peroxide. Since the peak times of hydrogen peroxide and gluconic acid in high performance liquid chromatography (HPLC) are similar, the peaks overlap seriously, and gluconic acid and hydrogen peroxide cannot be completely separated, which seriously affects the determination of gluconic acid content. Therefore, we use ultra-high performance liquid chromatography-tandem mass spectrometry (UPLC-MS / MS) to detect the content of gluconic acid.

[0063] Chromatographic conditions: The chromatographic column is ACQUITY HSS T3 1.8μm, 2.1x50 mm Column, aqueous phase (A): 5mmol ammonium acetate dissolved in 500mL ultrapure water, mobile phase (B): 5mmol ammonium acetate dissolved in 500mL methanol, column temperature 25℃, 10000-fold dilution for loading, 5μL per injection, flow rate 0.4mL / min. Gradient elution program is shown in Table 1.

[0064] Table 1 Liquid chromatography gradient elution program

[0065]

[0066] Mass spectrometry conditions: the ion source is an electrospray ion source (ESI), the ion source temperature (TEM) is 550°C, the spray gas (GS1) is 50.0 psi, the auxiliary heating gas (GS2) is 50.0 psi, the curtain gas (CUR) is 20.0 psi, the collision gas (CAD) is Medium, and the ionization voltage (IS) is -4500.0 V. The scanning mode of the mass spectrometer is the positive ion multiple reaction detection MRM scanning mode, and the mass spectrometry parameters of gluconic acid are shown in Table 2 below.

[0067] Table 2 Mass spectrometry analysis parameters

[0068]

[0069] (a) Preparation of standard solution: Accurately weigh a certain amount of gluconic acid standard, place it in a 10mL transparent volumetric flask, add methanol to dissolve and dilute to the scale line, cover and mix and shake to prepare a gluconic acid standard stock solution of corresponding mass and single concentration, seal and store at 4°C. Before use, quantitatively dilute the gluconic acid standard stock solution with methanol by gradient dilution method to 10ng / mL, 20ng / mL, 100ng / mL, 200ng / mL, 500ng / mL, 1000ng / mL of gluconic acid mixed standard solution, and store at 4°C for use.

[0070] (b) Sample pretreatment: 100 μL of GHAL suspension taken out at different times and 900 μL of 0.1 mol / L glucose reaction solution were taken, 10 μL of 10% trichloroacetic acid solution was added to precipitate protein, and then 100 μL of 0.1% Triton X-100 solution was added to break the emulsion so that gluconic acid was released from the liposomes. The mixture was centrifuged at 13,000 rpm for 5 min at 4°C, and the supernatant was taken as the sample mother liquor. A portion of the sample was diluted to 10,000 times, mixed, and then centrifuged at 13,000 rpm for 5 min at 4°C. The supernatant was collected in a brown loading bottle, mixed, and 5 μL was taken for analysis by the UPLC-MS / MS system.

[0071] (c) Establishment of standard curve: 10 ng / mL, 20 ng / mL, 100 ng / mL, 200 ng / mL, 500 ng / mL, and 1000 ng / mL of mixed standard solutions of gluconic acid were returned to room temperature before use, centrifuged at 13,000 rpm for 5 min at 4°C, the supernatant was collected and injected with 5 μL, and the standard curve and linear relationship were calculated using Graphpad Prism 8 software.

[0072] (5.2) Investigation of glucose oxidase activity (pH probe)

[0073] The activity of glucose oxidase was determined by measuring the change in the hydrogen ion content in the system to reflect the change in pH in the reaction system. 950 μL of PBS solution was added as the matrix solution to a 1.5 mL brown ep tube, and then 20 μL of 50 mM glucose solution was added to mix, 10 μL of 1 mM HPTS solution was added, and finally 20 μL of GHAL suspension was added to start the reaction. After mixing evenly, 200 μL of the reaction mixture was immediately taken out to a 96-well black board. The excitation spectra of different forms of HPTS in the reaction mixture within the range of 380-500 nm were scanned by a fluorescence microplate reader at an emission wavelength of 511 nm, and the ratio of F406 / F460 was calculated to reflect the generation of protons.

[0074] (6) Detection of hydrogen peroxide

[0075] (6.1) Qualitative analysis of hydrogen peroxide using 3,3′,5,5′-tetramethylbenzidine (TMB) method

[0076] Principle of the method: TMB is mainly hydrogen peroxide that generates free oxygen radicals under the catalysis of HRP. After the oxygen free radicals come into contact with the chromogenic substrate TMB, TMB forms an oxidized form and the reaction solution appears blue. When the color development reaction is terminated by an acidic solution (such as 0.5-2M H2SO4, 0.5M HCl, 1M H3PO4), the product turns from blue to yellow.

[0077] Sample processing: This experiment uses ethanol as the solvent, and the concentration of the colorimetric substrate TMB solution is prepared to be 10 mM, which is stored in a brown bottle at 4°C and protected from light. Use 4 mL of PBS solution as the reaction matrix solution, take 100 μL of the prepared 50 mM glucose solution, add TMB to dilute its final concentration to 0.1 mM, and then add 100 μL of the centrifuged purified liposome suspension. During the period, the suspension is shaken. After the reaction starts, the color change of TMB is recorded at 30 minutes.

[0078] (6.2) Quantitative analysis of hydrogen peroxide by fluorescence method

[0079] This experiment uses the Amplex Red fluorescent probe, which is currently a commonly used reagent for detecting hydrogen peroxide. The working principle of this fluorescent probe is that it can react with hydrogen peroxide in a 1:1 ratio under the catalysis of peroxidase to generate resorufin, which can produce strong red fluorescence. Hydrogen peroxide will combine with resorufin to turn the solution pink. The corresponding fluorescence intensity can be measured at an excitation wavelength of 550nm and an emission wavelength of 580nm to quantify hydrogen peroxide.

[0080] Sample treatment: prepare 50mM PBS solution (pH 7.4), 50mM glucose solution, Amplex Red solution dissolved in DMSO, and 0.1mg / mL peroxidase solution; use 940μL PBS solution as the reaction matrix solution, add 20μL of the prepared GAL liposome suspension to the PBS solution, then add 20μL glucose solution, 3.3μL Amplex Red solution and 10μL 0.1mg / mL peroxidase solution in sequence, mix well, take 200μL of the reaction solution and add it to a 96-well black board, set the fluorescence detection kinetic detection program, measure the fluorescence intensity within 30min at an excitation wavelength of 550nm and an emission wavelength of 580nm, and draw a reaction curve.

[0081] (7) Evaluation of ATP synthesis activity of GHAL

[0082] Chromatographic conditions: The chromatographic column is ACQUITY HSS T3 1.8μm, 2.1x50 mm Column, mobile phase (B): 5mmol ammonium acetate dissolved in 500mL methanol, aqueous phase (A): 5mmol ammonium acetate dissolved in 500mL ultrapure water, ammonia water adjusted pH to 8.5, column temperature 25℃, injection volume 5μL, flow rate 0.4mL / min. The gradient elution program is shown in Table 3.

[0083] Table 3 Liquid chromatography gradient elution program

[0084]

[0085] Mass spectrometry conditions: the ion source is an electrospray ion source (ESI), the ion source temperature (TEM) is 550°C, the spray gas (GS1) is 50.0 psi, the auxiliary heating gas (GS2) is 50.0 psi, the curtain gas (CUR) is 20.0 psi, the collision gas (CAD) is Medium, and the ionization voltage (IS) is -4500.0 V. The scanning mode of the mass spectrometer is the positive ion multiple reaction detection MRM scanning mode, and the mass spectrometry parameters of ATP are shown in Table 4 below.

[0086] Table 4 Mass spectrometry analysis parameters

[0087]

[0088] (a) Preparation of standard solution: Weigh a certain amount of ATP-Na2 standard accurately, place it in a 10mL transparent volumetric flask, add pure water to dissolve and dilute to the scale line, cover and mix, shake well, prepare a standard stock solution of ATP-Na2 with the corresponding mass and single concentration, seal and store at 4°C. Before use, quantitatively dilute the ATP-Na2 standard stock solution with methanol into 2ng / mL, 5ng / mL, 10ng / mL, 20ng / mL, 50ng / mL, 100ng / mL, 200ng / mL ATP-Na2 mixed standard solutions, and store at 4°C for use.

[0089] (b) Sample pretreatment: 100 μL of the GHAL and 50 mM glucose reaction solution taken out at different times was added with 10 μL of 10% trichloroacetic acid solution to precipitate the protein, and then 100 μL of 0.1% Triton X-100 solution was added to break the liposomes so that ATP was released from the liposomes. The mixture was centrifuged at 13,000 rpm for 5 min at 4°C, and the supernatant was taken out as the sample mother liquor. A portion of the sample was diluted to 100 times, mixed, and centrifuged at 13,000 rpm for 5 min at 4°C. The supernatant was collected in a brown loading bottle, mixed, and 5 μL was taken for UPLC-MS / MS analysis.

[0090] (c) Establishment of standard curve: 2 ng / mL, 5 ng / mL, 10 ng / mL, 20 ng / mL, 50 ng / mL, 100 ng / mL, and 200 ng / mL ATP-Na2 mixed standard solutions were returned to room temperature before use, centrifuged at 13,000 rpm for 5 min at 4°C, the supernatant was collected and loaded, and the solution was diluted 100 times for loading. 5 μL was injected each time, and Graphpad Prism 8 software was used to calculate the standard curve and linear relationship.

[0091] 3. Test results

[0092] 1. GHAL particle size potential measurement

[0093] like Figure 1 As shown, the average particle size of the liposomes (GHAL) with added glucose oxidase, peroxidase and ATP synthase was 188.21±5.00 nm and the potential was -15.29±2.55 mV. Compared with GAL, the particle size and potential of GHL were almost unchanged.

[0094] 2. Transmission electron microscopy observation of GHAL morphology

[0095] like Figure 2As shown, most of the GHALs are uniform spherical structures with obvious double-layer membrane structures. The morphology is well maintained, which is similar to the particle size detection results. Most of the liposomes are maintained at around 200 nm, which is consistent with the expected results.

[0096] 3. Study on the stability of GHAL

[0097] The stability of the prepared GHAL was investigated for 7 days. Figure 3 It can be seen that the particle size of GHAL prepared by the thin film dispersion method changes within 100 nm at 4°C, and the PDI is around 0.30, indicating that GHAL has good dispersibility in PBS solution, and after being stored in vitro for one week, the morphology has basically not changed.

[0098] After GHAL was placed in a -80℃ environment for 30 days, its ATP synthesis activity was evaluated. Figure 3 As shown, after 30 days of storage, GHAL can still oxidize glucose to produce protons, forming proton motive force potential energy to drive ATP synthase to synthesize ATP. After 1 hour of reaction, the ATP content in the solution can still reach 1.35μmol / L. The results show that the activity of ATP synthase is affected, but still shows 25% of the original ATP synthesis capacity.

[0099] 4. Results of basic investigation on biocompatibility of GHAL

[0100] Figure 4 As shown, through the cell proliferation experiment, it can be seen that GHAL has no obvious cytotoxicity to L02 cells. The experimental results show that GHAL has no obvious cytotoxicity to L02 cells.

[0101] 5. Glucose oxidase activity results in GHAL

[0102] The glucose oxidase activity of GHAL was further evaluated by comprehensively evaluating the degree of glucose oxidation by GAL and GHAL. Figure 5 It was found that the gluconic acid produced by the GAL group reached 13.00mmol / L at 6h, and the maximum reaction rate (Vmax) was 15.91mmol / L. In comparison, the gluconic acid content of the GHAL group reached 15.91mmol / L at 6h, and the maximum reaction rate (Vmax) was 17.68mmol / L, showing a better glucose oxidation ability. The results showed that the glucose oxidase activity in the GHAL group was higher, proving that the introduction of peroxidase in the system played a role in decomposing part of the hydrogen peroxide, thus proving that the redox system of the "artificial mitochondria" system was successfully constructed and had a certain glucose oxidation activity.

[0103] 6. Changes in hydrogen ion content of GHAL

[0104] To monitor the proton capacity generated by GHAL in the reaction mixture, the pH changes over time were determined by recording the fluorescence spectrum of HPTS as a pH-sensitive probe.

[0105] The changes in hydrogen ion concentrations in the GAL and GHAL reaction systems within 30 min were fitted, and the HPTS fluorescence intensity in the GHAL group decreased with time. We measured the changes in pH by measuring the characteristic peak intensities at 460 and 405 nm in the corresponding excitation spectra, such as Figure 6 As shown in the figure, as the reaction time increases, the fluorescence intensity at 460nm gradually decreases. On the contrary, the fluorescence intensity at 405nm gradually increases. This result shows that as the reaction proceeds, the acidity of the system becomes stronger and stronger. According to the pH calculation formula pH = a + bx + c / x + dx 2 +e / x 2 +fx 3 +g / x 3 (wherein a=6.13, b=2.69, c=-0.108, d=-1.65, e=0.013, f=0.39, g=-0.082) (referenced from Hazard A, Montemagno C. Improved purification for thermophilic F1F0 ATP synthase using n-dodecyl beta-D-maltoside. Arch Biochem Biophys. 2002 Nov1; 407(1):117-24.), the pH change of the GHAL system reached 0.30 at 60 min, while the pH change of the GAL system only reached 0.18 at 60 min. The results showed that the pH change of GHAL was more obvious than that of GAL, and the acidity in the GHAL system was stronger, indicating that the glucose oxidase activity of the GHAL system was higher, the peroxidase decomposed the hydrogen peroxide in the system, and the inhibition of hydrogen peroxide on the activity of glucose oxidase was relieved, so that more glucose was efficiently converted into gluconic acid, providing more protons for the system.

[0106] 7. Changes in hydrogen peroxide content of GHAL

[0107] When TMB is oxidized, the reaction solution changes from light yellow to blue, and after the solution is acidified, it turns yellow-brown. Figure 7As can be seen in Figure A, after GHAL reacts with glucose, the reaction solution immediately changes from colorless to visible blue, proving that there is a large amount of hydrogen peroxide in the solution. This is due to the byproduct hydrogen peroxide produced by the oxidation of glucose by glucose oxidase. As the reaction time increases, glucose oxidation produces a large amount of gluconic acid, which lowers the pH of the solution. After the solution is acidified, the blue solution gradually deepens and becomes yellow-brown, further indicating that the redox system in GHAL is successfully constructed and the loaded glucose oxidase has good activity.

[0108] from Figure 7 As can be seen from Figure B, with the increase of time, the fluorescence intensity at 595nm decreases significantly, indicating that the hydrogen peroxide content in the system gradually decreases with the increase of time, and the hydrogen peroxide in the system is at a low level, which further proves that the peroxidase in GHAL has a certain activity.

[0109] 8. Evaluation and comparison of ATP synthesis activity of GHAL

[0110] This experiment mainly evaluated the ATP synthesis activity of GHAL under the condition of exogenous ADP and Pi, and GAL was used as the control group. Figure 8 As shown in the results, the maximum reaction rate (Vmax) of ATP synthesis in the GHAL system was 13.06 μmol / L, and the maximum concentration of its content in 6 hours reached 11.78 μmol / L; in comparison, the maximum reaction rate (Vmax) of ATP synthesis in the GAL system was only 11.28 μmol / L, and the maximum concentration of ATP content in 6 hours was 9.74 μmol / L. By comparison, the GHAL group produced significantly more ATP than the GAL group, and the reaction rate was faster, which further confirmed that the removal of hydrogen peroxide in the system can reduce the inhibitory effect on the activity of glucose oxidase caused by the accumulation of hydrogen peroxide, thereby promoting more glucose to be converted into gluconic acid, further generating more protons to form a high concentration of proton motive force potential energy, making ATP synthase operate faster and ATP production more efficient.

[0111] The above description is only a preferred embodiment of the present invention and is not intended to limit the present invention. For those skilled in the art, the present invention may have various modifications and variations. Any modification, equivalent replacement, improvement, etc. made within the spirit and principle of the present invention shall be included in the protection scope of the present invention.

Claims

1. An artificial mitochondria, characterized in that: It includes artificial biomembranes and all-organic molecules loaded by the artificial biomembrane, wherein the all-organic molecules include glucose oxidase, peroxidase and ATP synthase.

2. The artificial mitochondria according to claim 1, characterized in that The artificial biological membrane includes at least one of a liposome membrane, a polymer membrane, a polymer micelle, a cell membrane and an organelle membrane.

3. The artificial mitochondria according to claim 1, characterized in that The loading rate of glucose oxidase is 3%-12%, the loading rate of peroxidase is 5%-21%, and the loading rate of ATP synthase is 5-15%.

4. The artificial mitochondria according to claim 1, characterized in that The particle size of artificial mitochondria is 50 to 2000 nm.

5. The artificial mitochondria according to claim 1, characterized in that: The Zeta potential of artificial mitochondria is -50~+50mV.

6. The method for constructing an artificial mitochondria according to any one of claims 1 to 5, characterized in that: The steps include: S1 prepares the membrane; The S2 membrane is mixed with glucose oxidase and peroxidase in a solvent system to obtain a suspension; S3 performs extrusion filtration on the suspension; The treated liquid after S4 extrusion filtration is mixed with ATP synthase in a solvent system, and the solvent is removed to obtain artificial mitochondria.

7. The method for constructing an artificial mitochondria according to claim 6, characterized in that: The construction method includes at least one of the features (1) to (3): (1) In S1, lecithin and cholesterol are dissolved in a solvent system, and the solvent is removed to obtain a lipid membrane; (2) In S2, glucose oxidase and peroxidase are dissolved in PBS to form a system solution, and the system solution is added to the membrane to hydrate and obtain a suspension; (3) In S3, the suspension is filtered through a polytetrafluoroethylene filter membrane and then squeeze-filtered through a polycarbonate membrane.